Concurrent Investment Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
32,050
+2,000
+7% +$9.81K ﹤0.01% 1939
2026
Q1
$103K Buy
30,050
+50
+0.2% +$169 ﹤0.01% 1823
2025
Q4
$84.9K Buy
+30,000
New +$155K ﹤0.01% 1718
2025
Q3
– Sell
-17,604
Closed -$104K – 1505
2025
Q2
$104K Buy
17,604
+511
+3% +$2.94K ﹤0.01% 1327
2025
Q1
$109K Buy
+17,093
New +$165K ﹤0.01% 1176

Other funds holding ASPN

Concurrent Investment Advisors's ASPN Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Aspen Aerogels (ASPN) stake by 6.7% in Q2 2026, buying an estimated $9.81K and bringing the position to 32,050 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Concurrent Investment Advisors first reported a position in ASPN in Q1 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Concurrent Investment Advisors held 32,050 shares of Aspen Aerogels worth $203K as of Q2 2026.
  • Concurrent Investment Advisors bought 2,000 Aspen Aerogels shares in Q2 2026, an estimated $9.81K.
  • Aspen Aerogels made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1939 holding.
  • Concurrent Investment Advisors first reported a position in Aspen Aerogels in Q1 2025 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.